Abstract Objectives: The aim of this study was to investigate the relationships among bone mineral densities (BMD) in the calcaneus and leg activity of daily living (L-ADL) in rheumatoid arthritis (RA) patients. Methods: We measured and compared calcaneus BMD using single X-ray absorptiometry and lumbar spine and femoral neck BMD using dual X-ray absorptiometry in 158 Japanese female outpatients with RA and 358 normal controls (NC). Results: Regardless of whether the women were premenopausal or postmenopausal, calcaneus and femoral neck BMDs in the RA group were significantly lower than in the NC group. Calcaneus BMD correlated with the modified health assessment questionnaire, L-ADL score, and 10-m walking time, regardless of whether the patients were premenopausal or postmenopausal (P<0.01). Conclusions: We conclude that calcaneus BMD reflects the L-ADL of RA patients very well and allows us to perform the same level of BMD evaluation as that with current BMD measurement methods.
Introduction
The physical activity of patients with rheumatoid arthritis (RA) is limited to various degrees depending on the site and severity of the various lesions [1, 2, 3, 4, 5, 6] . Immobilization caused by pain from these lesions can lead to a systematic decrease in bone [7] and significant increase in fractures in RA patients, which markedly affects their daily activities and quality of life. Therefore, a simpler method is needed to evaluate bone mineral density (BMD) which will allow for mass screening of osteoporosis in RA patients. Looking for such a method, we focused on the calcaneus, a weight-bearing, highly cancellous bone that is less affected by bone fracture. We measured its BMD using single X-ray absorptiometry (SXA) and that of the lumbar spine and femoral neck using dual X-ray absorptiometry (DXA) to compare and investigate how daily life activity, especially lower limb activity, and corticosteroid drug usage affect bone decrease in RA patients.
Material and methods

Patients
The subjects (RA group) were 158 Japanese female outpatients at our department who were diagnosed as having RA according to the revised 1987 diagnostic criteria of the American Rheumatism Association [8] . Their mean age was 55.6 years (range , and the mean duration of the disease was 12.1 years (range 1-42). Fifty patients were premenopausal (premenopausal group), 44 were postmenopausal for less than 10 years (<10 years postmenopausal group), and 64 were postmenopausal for more than 10 years ( ‡10 years postmenopausal group). Steinbrocker's stage 1 [9] was observed in 14 patients, stage 2 in 66, stage 3 in 60, and stage 4 in 18. Class I of Steinbrocker was observed in 19 patients, class II in 75, and class III in 64. Forty-seven patients had histories of corticosteroid administration. More than 1 year had passed since any surgery such as artificial joint replacement had been performed in all patients.
Controls
The normal controls (NC group) were 382 normal Japanese females without histories of disease or drug administration affecting bone metabolism. Their mean age was 54.8 years (range . The premenopausal group consisted of 126 control females, the <10 years postmenopausal group had 128 control females, and the ‡10 years postmenopausal group had 128 control females. Controls were age-matched to the patients.
Measurements
The right calcaneus was used to measure BMD by SXA using a model SXA-2000 osteoanalyzer (Dove, Los Angeles, Calif., USA). Scanning of 14 cross-settings was performed at a width of 3 mm by a single X-ray at 27.5 keV, and the minimum of the mean values in nine serial slices was automatically calculated as the measurement value. In SXA, both heterogeneity and positioning of the calcaneus are overcome by a unique analysis method, as a result, the CV percentage is less than 1%, showing high accuracy and reproducibility [10, 11] . Lumbar spine and femoral neck BMDs were measured by DXA (Lunar, Madison, Wis., USA).
The degree of RA activity was evaluated using the Lansbury index [12] , erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP). Patient activities of daily life (ADL) were evaluated using a modified health assessment questionnaire (M-HAQ) [13] , leg ADL (L-ADL) score, and 10-m walking time. The L-ADL score was averaged from the scores for three questions on the M-HAQ: ''Can you get in and out of bed?'', ''Can you walk outdoors on flat ground?'', and ''Can you get in and out of the car?'' Statistical analysis All data were processed on a Macintosh computer (Apple, Cupertino, Calif., USA) using Office software (Microsoft, Redmond, Wash., USA). The statistical procedures were accomplished using version 4.5 Stat View software (SAS, Cary, N.C., USA). Data were expressed as means±SD. Student's t-test for unpaired values and between-group Mann-Whitney U test were used, when appropriate, to compare differences for continuous variables. Spearman's coefficient was used to test correlations. The relationships between BMD and each of the other criteria were analyzed by linear regression. In each analysis, P<0.05 was considered statistically significant. (Fig. 1 ). Calcaneus and femoral neck BMDs were significantly lower in the RA group than in the NC group before and after menopause, whereas lumbar spine BMD was significantly lower in the RA group than in the NC group only in postmenopausal women (Table 2) .
Results
Comparison
Relationship between bone mineral densities of the calcaneus, lumbar spine, and femoral neck We investigated the relationship between calcaneus BMD and both lumbar spine and femoral neck BMDs in the RA and NC groups. Significant correlations were observed in the NC group between calcaneus and lumbar spine BMD (r=0.776, P<0.01) and calcaneus and femoral neck BMD (r=0.774, P<0.01). In the RA group, significant correlations were also observed between the calcaneus and lumbar spine BMD (r=0.797, P<0.01) and between the calcaneus and femoral neck BMD (r=0.756,P<0.01) (Fig. 2) .
Relationship between bone mineral density and other criteria Duration of RA Calcaneus and femoral neck BMD correlated with the duration of RA in both the premenopausal and <10 years postmenopausal groups. Lumbar spine BMD correlated with duration of RA in the <10 years postmenopausal group. There were no significant correlations between BMD and duration of RA in the ‡10 years postmenopausal group (Table 3) .
Lansbury index
The calcaneus and femoral neck BMDs correlated with the Lansbury index in both postmenopausal groups (<10 years and ‡10 years). The lumbar spine BMD correlated with only the Lansbury index in the ‡10 years postmenopausal group.
Erythrocyte sedimentation rate
The calcaneus BMD correlated with ESR in both postmenopausal groups. Lumbar spine and femoral neck BMDs had no correlation with ESR in any of the three groups.
C-reactive protein
The calcaneus BMD correlated with CRP in the ‡10 years postmenopausal group. Lumbar spine BMD did not correlate with CRP in any group, and femoral neck BMD correlated with CRP in the premenopausal group.
Modified health assessment questionnaire
Calcaneus and femoral neck BMDs correlated with the M-HAQ in all three groups, while the lumbar spine BMD correlated with M-HAQ in the premenopausal and <10 years postmenopausal groups. Leg activity of daily living score Calcaneus, lumbar spine, and femoral neck BMDs of RA patients showed significant correlations with L-ADL score in all three groups. Especially the calcaneus BMD showed a significant correlation with L-ADL in the three groups premenopause, <10 years after menopause, and ‡10 years after menopause.
Ten-meter walking time
The calcaneus BMD correlated with 10-m walking time in all three groups, while the lumbar spine and femoral neck BMDs correlated with it in both postmenopausal groups.
Effect of corticosteroids
Forty-seven patients had histories of oral corticosteroid administration ( Table 4 ). The mean daily dose, converted to prednisolone, was 5.3±2.2 mg, and the mean administration period was 53.7 months. No significant difference was observed in age, height, weight, BMI, or duration of RA between the corticosteroid and noncorticosteroid groups. The L-ADL score, Lansbury index, ESR, and CRP were significantly higher in the corticosteroid group, and calcaneus and femoral neck BMDs were significantly lower in the corticosteroid group. However, lumbar spine BMD did not differ between the corticosteroid and noncorticosteroid groups.
Discussion
Using the calcaneus to measure BMD has been reported as useful and comparable to the more common methods of BMD evaluation [10, 11, 14] . In this study, BMD of the calcaneus correlated highly with that of the lumbar spine and femoral neck in both the RA and NC groups. Thus, using the calcaneus to measure BMD seems to be useful along with measures of lumbar spine and femoral neck BMDs. The reproducibility of calcaneus BMD by SXA was high (in vitro CV <1%, in vivo CV 0.59%) [10, 11] . Due to its convenience and low X-ray exposure, SXA has been used to screen for low BMD. The calcaneus bone has the following characteristics:
1. Fracture due to osteoporosis rarely occurs 2. Age-related changes in bone morphology are negligible 3. There is little surrounding soft tissue 4. It is 90-95% cancellous bone [14] Therefore, measurement of calcaneus BMD is precise and accurately reflects the amount of cancellous bone. Thus the calcaneus may be useful for early detection, diagnosis, and evaluation of the effects of metabolic bone disease treatments [14] . Deformation of the lumbar spine and compression fractures, femoral neck bone fractures, and hip replacement are often seen in RA patients, and they all affect BMD measurement. Using the calcaneus to measure BMD removes these effects, making it very suitable for long-term follow-up of RA patients. It is also easy and quick to measure.
It has been suggested that osteoporosis in RA is juxtaparticular [2, 3, 5, 15, 16, 17, 18, 19, 20, 21, 22] , generalized [4, 17, 23, 24, 25, 26] , and affected by various factors such as sex, age, duration of disease, menopause, history of drug administration, endocrine metabolic abnormalities, history of surgery, and immobility [2, 4, 5, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26] . In 1965, Duncan et al. [17] histologically examined the ribs of RA patients to evaluate the amount of bone and found systemic osteoporosis. In 1973, Reid et al. [23] measured the amount of calcium in the entire body by neutron activation analysis and observed a 5.3-5.8% decrease in RA patients. Muller et al. [15] measured the ulna by single photon absorptiometry, while Sambrook et al. [26] measured the lumbar spine and femoral neck by dual photon absorptiometry (DPA), and both study teams observed a significant decrease in BMD of RA patients compared with normal groups.
Also in 1995, Laan et al. [5] reported that calcaneus BMD in RA patients was significantly lower than in their control group. Their results agreed with ours: calcaneus and femoral neck BMDs were significantly lower in the RA group than in the NC group. Lumbar spine BMD was significantly lower in the RA group than in the NC group after menopause. Bone decrease in RA patients had been enhanced by menopause.
In a cross-sectional study, Sambrook et al. [4] measured lumbar spine and femoral neck BMDs by DPA in RA patients and found them to be significantly lower than in a normal group. In addition, they performed multiple regression analysis and reported positive correlations between femoral neck BMD and age, body weight, and physical activity calculated by conversion of oxygen consumption. In this study, calcaneus BMD was significantly lower in RA patients than in normal females and correlated significantly with decreased leg function secondary to enhanced RA activity. Immobilization due to enhanced RA may be reflected earlier by the calcaneus, which is markedly more affected by weight bearing than either the lumbar spine or femoral neck. This appears to be associated with disuse bone atrophy induced by impaired leg function. The calcaneus reflects leg activity in RA patients well, and its BMD can be an index of leg activity in these patients.
Sambrook et al. [4] reported an increase in lumbar spine BMD with the number of deliveries and no significant association between a decrease in BMD and lowdose corticosteroid administration (mean daily dose 8 mg). Their longitudinal study revealed that BMD is more closely associated with generalized disuse than with low steroid administration [27] . Studies on the effects of steroids on BMD have shown contradictory results, from no effects [17, 24, 26 ] to a significant decrease in BMD [4, 25, 27, 28] . In our study, calcaneus BMD was significantly low in the <10 years postmenopausal group and, within this group, those receiving corticosteroid drugs did show lower values than those receiving no corticosteroids; but the difference was not significant.
We considered that disease activity was high in RA patients receiving corticosteroid drugs, but an average of 5 mg/day did not cause steroid osteoporosis. However, in postmenopausal patients with limited ADL, even low-dose steroids may be involved in the progression of osteoporosis. Rheumatoid arthritic patients are treated with drugs such as analgesics, antirheumatoid drugs, metabolic antagonists, gold compounds, and vitamin D3 preparations, which further complicates interpretation of results [29, 30, 31, 32, 33, 34, 35] .
Bone mineral density studies in patients with complex factors such as RA are still inadequate, and more clinical studies along with the development of more advanced measurement are needed. In addition, to evaluate the direct effects of RA on BMD, measurement of BMD in patients with early-stage RA that have not been affected by drugs or immobilization is necessary. We conclude that calcaneus BMD reflects the L-ADL of RA patients very well and allows the same level of BMD evaluation as that of current BMD measurement methods. 
